Danubio


Paclitaxel
  • Highly lipophilic drug ensuring anti-proliferative action.
  • Efficacy and safety proven as a useful anti-proliferative treatment in coronary arteries.
  • 2.5µg/mm² dosage fully bioavailable on the surface of the balloon.
      SpeedPax Technolgy
  • Paclitaxel polymer free technology combined with a structural forming agent ensures an optimal drug transfer after a 30-second balloon inflation time.
  • Homogeneous coating applied all around the contact surface.
  • Consistent coating ensuring delivery of at least 75% of the drug at the lesion site.
      Natural combination
  • Treatment of choice for the side branch after the Nile Pax treatment of the main branch.
  • Same molecule, same dosage, different technology and still polymer free.

    • There is no clinicals

    There is no case libary

    Haut

    © Minvasys 2012, all rights reserved / Legals / Sitemap / Contact